Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. News and Stories
  4. Ask an expert: Why is it so important to get a regular pap test?

Ask an expert: Why is it so important to get a regular pap test?

Stories Jan 17, 2024 4 minutes

For this year’s Cervical Cancer Awareness Month, our expert shares information about cervical cancer prevention and the importance of screening.

In Canada, an estimated 1,550 people were diagnosed with cervical cancer in 2023. Around 200 new cases are recorded in British Columbia every year. Vancouver Coastal Health Research Institute researcher and gynecologic oncologist Dr. Janice Kwon explains the risk factors for developing cervical cancer and why screening for abnormal cells, even before symptoms develop, is crucial. 

Q: What are some of the early symptoms of cervical cancer?
A: There are typically no warning signs of early stage cervical cancer, which is why screening is an important approach to catching pre-cancerous cells before the disease progresses to cancer. Even early stage cancer may not cause any symptoms. More advanced cervical cancer is often associated with abnormal vaginal bleeding or discharge, such as bleeding after intercourse or between cycles. 

Only five per cent of pap smears return with abnormal results, most of which are not cancer. Only a very small percentage of these women will have pre-cancerous cells, which can be effectively treated to avoid cancer. On the other hand, most women who are diagnosed with advanced cervical cancer have never been screened, or have not been screened in over 10 years. This is why it is imperative to get regular pap tests, even if you are healthy and do not have any symptoms. 

Q: What causes cervical cancer?
A: The primary cause of cervical cancer is the human papillomavirus (HPV). HPV is transmitted through skin-to-skin contact during sex. About 70 per cent of sexually active people in Canada are exposed to this virus at some point in their lifetime. However, only a small percentage of individuals will develop cervical cancer following infection.

The best protection against cervical cancer is the HPV vaccine, which produces antibodies against over 100 different types of HPV strains — some of which are also associated with oropharyngeal (head and neck) cancers, genital warts and anal and penile cancers. 

Starting in grade six, students in B.C. can receive a free HPV vaccine through their school vaccination programs. 

Q: What lifestyle changes can I make to reduce my risk of developing cervical cancer?
A: 
Stop smoking. Smoking is associated with a higher risk of cervical cancer because it weakens the immune system. People who live with immunocompromised conditions such as HIV, or who take immunosuppressant medications following an organ transplant may also be at greater risk of developing cervical cancer. When you are unable to clear the virus from your system, it can cause changes in the cells of the cervix and potentially transform into cancer. 

Q: How often do I get a pap test?
​​​​​​​A: 
The guidelines in B.C. recommend getting regular pap tests starting at the age of 25 years. Following a normal test result, a screening only needs to be repeated every three years. People at higher risk of developing cervical cancer, such as immunocompromised individuals, should have a pap smear every year.

The next iteration of guidelines will be moving to HPV testing as a primary screen for older individuals. In January 2024, we will be transitioning to HPV testing instead of pap smear screening for people over age 55. The reason for this is that HPV testing casts a broader net, so it is less likely that pre-cancerous cells will be missed. 

Cervix self-screening is also being introduced as an alternative to the in-clinic pap test. These test kits enable a person to test themselves at home, making it more accessible to those who may not have a family doctor or who are reluctant to have an examination. This can also be a welcome alternative toward addressing lower rates of cervical cancer screening among marginalized populations.

Q: What does it mean if my test results are abnormal, and what are my treatment options?
​​​​​​​A: 
While there are varying degrees of abnormality, a mildly abnormal pap result occurs when there are some abnormal cells present, but typically resolves on its own. However, a highly abnormal test result requires further investigation, such as a colposcopy – a specialized procedure in which a magnifying instrument called a colposcope is used to closely examine the cervix – to screen for any precancerous cells. A biopsy of the cervix is also often taken for confirmation purposes.

If pre-cancerous cells are detected, the recommended treatment is generally a minor procedure called a loop electro surgical excision procedure (LEEP), which is performed under local anesthetic in a clinic setting. 

After treatment, there is a 10 per cent chance that the pre-cancer can return, and that additional treatment will be needed. Therefore, patients are usually scheduled to be followed up six months following the LEEP procedure. It is also recommended that patients receive the HPV vaccine if they haven’t already.

Dr. Janice Kwon is a gynecologic oncologist and professor in the Department of Obstetrics and Gynecology at the University of British Columbia. She serves as chair of the Priority and Evaluations Committee at BC Cancer, the Research & Outcomes Evaluation Committee for the BC Cancer Surgery Network and the National BRCA Collaborative. She currently holds a Health Professional Investigator Award from the Michael Smith Foundation for Health Research.

 

Researchers

Janice Kwon

Share:

  • Facebook
  • Linkedin
  • Twitter
  • Email

Related Research Centres/Programs

Ovarian Cancer Research Centre

Get the latest research headlines in your inbox

Subscribe

Recent News and Stories

Type
Announcement

Celebrating the life and distinguished career of Dr. Marcel Dvorak

May 14, 2025
Type
Stories

More equitable representation needed in Parkinson’s research

May 9, 2025 parkinsons, patient engagement, women
Type
Stories

Gamified stroke recovery improves arm function

May 8, 2025 stroke, rehabilitation
See more news

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy